Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-25-008667
Filing Date
2025-06-16
Accepted
2025-06-16 17:00:51
Documents
7
Effectiveness Date
2025-06-16

Document Format Files

Seq Description Document Type Size
1 S-8 capr-20250609xs8.htm S-8 101005
2 EX-4.7 capr-20250609xex4d7.htm EX-4.7 132805
3 EX-4.8 capr-20250609xex4d8.htm EX-4.8 92677
4 EX-5.1 capr-20250609xex5d1.htm EX-5.1 12449
5 EX-23.1 capr-20250609xex23d1.htm EX-23.1 3833
6 EX-FILING FEES capr-20250609xexfees.htm EX-FILING FEES 23388
7 GRAPHIC capr-20250609xex5d1002.jpg GRAPHIC 4308
  Complete submission text file 0001558370-25-008667.txt   373514
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-288088 | Film No.: 251050935
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)